Mixed-species malaria infections in humans

Trends in Parasitology

Volumn 20, Issue 5, 2004, Pages 233-240

  Mayxay, Mayfong ^a,b   Pukrittayakamee, Sasithon ^c   Newton, Paul N ^a,d   White, Nicholas J ^a,c,d  

^a MAHOSOT HOSPITAL   (Laos)

^b NATIONAL UNIVERSITY OF LAOS   (Laos)

^c MAHIDOL UNIVERSITY   (Thailand)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMISIN DERIVATIVE; ARTESUNATE; AZITHROMYCIN; CHLOROQUINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; PRIMAQUINE; QUININE SULFATE; SULFADOXINE;

ANOPHELES; ASIA; CONVALESCENCE; DISEASE SEVERITY; DRUG HALF LIFE; EPIDEMIOLOGICAL DATA; ERYTHROCYTE; GAMETOCYTE; GEOGRAPHY; HEALTH SURVEY; HOSPITAL ADMISSION; HOST PARASITE INTERACTION; HUMAN; IMMUNITY; LONGITUDINAL STUDY; MALARIA; MALARIA FALCIPARUM; MIXED INFECTION; PARASITE DEVELOPMENT; PARASITE INCIDENCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PREVALENCE; RELAPSE; REVIEW; SENSITIVITY ANALYSIS;

ANIMALS; HOST-PARASITE RELATIONS; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PREVALENCE;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOA;

EID: 1942423286     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2004.03.006     Document Type: Review

References (70)

1. White N.J. Malaria. Cook G.C., Zumla A. Manson's Tropical Diseases. 2003;1205-1295 Saunders.
2. Nosten F., et al. Effects of Plasmodium vivax malaria in pregnancy. Lancet. 354:1999;546-549.
3. Thompson C., et al. Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis. Clin. Infect. Dis. 33:2001;676-685.
4. Howard S.C., et al. Methods for estimation of association between multiple species parasite infections. Parasitology. 122:2001;233-251.
5. Looareesuwan S., et al. High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand. Lancet. 2:1987;1052-1055.
6. McKenzie F.E., Bossert W.H. Multispecies Plasmodium infections of humans. J. Parasitol. 85:1999;12-18.
7. Pukrittayakamee S., et al. Therapeutic responses to antibacterial drugs in vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 95:2001;524-528.
8. Mayxay M., et al. Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria. Am. J. Trop. Med. Hyg. 65:2001;588-592.
9. Zhou M., et al. High prevalence of Plasmodium malariae and Plasmodium ovale in malaria patients along the Thai-Myanmar border, as revealed by acridine orange staining and PCR-based diagnosis. Trop. Med. Int. Health. 3:1998;304-312.
10. Kawamoto F., et al. How prevalent are Plasmodium ovale and P. malariae in East Asia. Parasitol. Today. 15:1999;422-426.
11. Boyd M.F., Kitchen S.F. Simultaneous inoculation with Plasmodium vivax and falciparum. Am. J. Trop. Med. 17:1937;855-861.
12. Boyd M.F., Kitchen S.F. Vernal vivax activity in persons simultaneously inoculated with Plasmodium vivax and Plasmodium falciparum. Am. J. Trop. Med. 18:1938;505-514.
13. Mayne B., Young M.D. Antagonism between species of malaria parasites in induced mixed infections. Public Health Rep. 53:1938;1289-1291.
14. Jeffery G.M. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull. World Health Organ. 35:1966;873-882.
15. Cohen J.E. Heterologous immunity in human malaria. Q. Rev. Biol. 48:1973;467-489.
16. Molineaux L., et al. A longitudinal study of human malaria in the west African Savanna in the absence of control measures: Relationships between different Plasmodium species; in particular Plasmodium falciparum and Plasmodium malariae. Am. J. Trop. Med. Hyg. 29:1980;725-737.
17. Maitland K., et al. Plasmodium vivax and P. falciparum: biological interactions and the possibility of cross-species immunity. Parasitol. Today. 13:1997;227-231.
18. Bruce M.C., Day K.P. Cross-species regulation of Plasmodium parasitemia in semi-immune children from Papua New Guinea. Trends Parasitol. 19:2003;271-277.
19. Gunewardena D.M., et al. Patterns of acquired anti-malarial immunity in Sri Lanka. Mem. Inst. Oswaldo Cruz. 89:(Suppl. 2):1994;63-65.
20. Richie T.L. Interactions between malarial parasites infecting the same vertebrate host. Parasitology. 96:1988;607-639.
21. Luxemburger C., et al. Treatment of vivax malaria on the western border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:1999;433-438.
22. Rosenberg R., et al. Highly efficient dry season transmission of malaria in Thailand. Trans. R. Soc. Trop. Med. Hyg. 84:1990;22-28.
23. Gordon D.M., et al. Significant of circumsporozoite-specific antibody in the natural transmission of Plasmodium falciparum, Plasmodium vivax, and Plasmodium malariae in an aboriginal (Orang Asli) population of central peninsular Malaysia. Am. J. Trop. Med. Hyg. 45:1991;49-56.
24. Fonenille D., et al. Malaria transmission and vector biology on Sainte Marie Island, Madagascar. J. Med. Entomol. 29:1992;197-202.
25. Burkot T.R., et al. The prevalence of naturally acquired multiple infections of Wuchereria bancrofti and human malarias in anopheles. Parasitology. 100:1990;369-375.
26. Sirichaisinthop, J. (2002) The P. vivax situation in Thailand, Past and Present. Abstract: presented at the Meeting of vivax malaria research: 2002 and beyond, Siam City Hotel, Bangkok, Thailand, February 3-8, 2002.
27. Kobayashi J., et al. Current status of malaria infection in a southeastern province of Lao PDR. Southeast Asian J. Trop. Med. Public Health. 29:1998;236-241.
28. Toma H., et al. A field study on malaria prevalence in southeastern Laos by polymerase chain reaction assay. Am. J. Trop. Med. Hyg. 64:2001;257-261.
29. Alifrangis M., et al. IgG reactivities against recombinant Rhoptry-Associated Protein-1 (rRAP-1) are associated with mixed Plasmodium infections and protection against disease in Tanzanian children. Parasitology. 119:1999;337-342.
30. May J., et al. Impact of subpatent multi-species and multi-clonal plasmodial infections on anaemia in children from Nigeria. Trans. R. Soc. Trop. Med. Hyg. 94:2000;399-403.
31. Pinto J., et al. Mixed-species malaria infections in the human population of Sao Tome island, West Africa. Trans. R. Soc. Trop. Med. Hyg. 94:2000;256-257.
32. Tobian A.A., et al. Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae, and P. ovale in Kenya. J. Infect. Dis. 182:2000;558-563.
33. Baird J.K., et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am. J. Trop. Med. Hyg. 56:1997;621-626.
34. Siripoon N., et al. Cryptic Plasmodium falciparum parasites in clinical P. vivax blood samples from Thailand. Trans. R. Soc. Trop. Med. Hyg. 96:2002;70-71.
35. Smith T., et al. Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium. Am. J. Trop. Med. Hyg. 64:2001;262-267.
36. Price R.N., et al. Factors contributing to anemia in uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 65:2001;614-622.
37. Black J. Mixed infections with Plasmodium falciparum and P. malariae and fever in malaria. Lancet. 343:1994;1095.
38. Paul R.E.L., et al. Genetic analysis of Plasmodium falciparum infections on the northwestern border of Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:1999;587-593.
39. Mason D.P., McKenzie F.E. Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections. Am. J. Trop. Med. Hyg. 61:1999;367-374.
40. Mason D.P. Review and recent progress: the mathematical modeling of mixed species Plasmodium infections. Southeast Asian J. Trop. Med. Public Health. 31:2000;69-74.
41. McKenzie F.E., et al. Plasmodium malariae infection boosts Plasmodium falciparum gametocyte production. Am. J. Trop. Med. Hyg. 67:2002;411-414.
42. Graves P.M., et al. Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea. Parasitology. 96:1988;251-263.
43. Udomsangpetch R., et al. Febrile temperatures induce cytoadherence of ring-stage Plasmodium falciparum-infected erythrocytes. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11825-11829.
44. Gopinathan V.P., Subramanian A.R. Pernicious syndromes in Plasmodium infections. Med. J. Aust. 11/25:1982;568-572.
45. Gopinathan V.P., Subranmania A.R. Vivax and falciparum malaria seen at an Indian service hospital. J. Trop. Med. Hyg. 89:1986;51-55.
46. Krudsood S., et al. Hidden Plasmodium falciparum infections. Southeast Asian J. Trop. Med. Public Health. 30:1999;623-624.
47. Morishita K. Notes on mixed malaria infections, with special reference to antagonism among different species of malaria parasites, and their segregation by the use of special drugs. J. Formos. Med. Assoc. 3:1931;68-70.
48. Kremsner P.G., et al. Clindamycin is effective against Plasmodium falciparum but not against P. vivax in mixed infections. Trans. R. Soc. Trop. Med. Hyg. 83:1989;332-333.
49. Tijitra E., et al. Therapeutic efficacies of artesunate-sulfadoxine- pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrob. Agents Chemother. 46:2001;3947-3953.
50. Urdanetta M., et al. Evaluation of Spf66 malaria vaccine in Brazil. Am. J. Trop. Med. Hyg. 58:1998;378-385.
51. Reft W.A., et al. Diagnosis of Plasmodium vivax malaria using a specific deoxyribonucleic acid probe. Trans. R. Soc. Trop. Med. Hyg. 84:1990;630-634.
52. Snounou G., et al. The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bisseau. Trans. R. Soc. Trop. Med. Hyg. 87:1993;649-653.
53. Tirasophon W., et al. A highly sensitive, rapid, and simple polymerase chain reaction-based method to detect human malaria (Plasmodium falciparum and Plasmodium vivax) in blood samples. Am. J. Trop. Med. Hyg. 51:1994;308-313.
54. Rubio J.M., et al. Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in equatorial Guinea. Am. J. Trop. Med. Hyg. 60:1999;183-187.
55. Mehlotra R., et al. Random distribution of mixed species malaria infection in Papua New Guinea. Am. J. Trop. Med. Hyg. 62:2000;225-231.
56. Laoboonchai A., et al. PCR-based ELISA technique for malaria diagnosis of specimens from Thailand. Trop. Med. Int. Health. 6:2001;458-462.
57. Bunnag D., et al. Double blind randomized clinical trial of two different regimens of oral artesunate in falciparum malaria. Southeast Asian J. Trop. Med. Public Health. 22:1991;534-538.
58. Bunnag D., et al. Double blind randomized clinical trial of oral artesunate at once or twice daily dose in falciparum malaria. Southeast Asian J. Trop. Med. Public Health. 22:1991;539-543.
59. Bunnag D., et al. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian J. Trop. Med. Public Health. 22:1991;380-385.
60. van Vugt M., et al. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 60:1999;936-942.
61. Myint P.T., Shwe T. The efficacy of artemether (qinghaosu) in Plasmodium falciparum and P. vivax in Burma. Southeast Asian J. Trop. Med. Public Health. 17:1986;19-22.
62. Thimasarn K., et al. A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand. Southeast Asian J. Trop. Med. Public Health. 28:1997;465-471.
63. Karbwang J., et al. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet. 340:1992;1245-1248.
64. Harinasuta T., et al. Trials of mefloquine in vivax and mefloquine plus 'fansidar' in falciparum malaria. Lancet. i:1985;885-888.
65. Boudreau E.F., et al. Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand. Bull. World Health Organ. 66:1988;227-235.
66. Chongsuphajaisiddhi T., et al. A Phase III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. Bull. World Health Organ. 65:1987;223-226.
67. Vanijanonta S., et al. Therapeutic effects of chloroquine in combination with quinine in uncomplicated falciparum malaria. Ann. Trop. Med. Parasitol. 90:1996;269-275.
68. Wilairatana P., et al. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax in Thailand. Am. J. Trop. Med. Hyg. 61:1999;973-977.
69. Schuurkamp J., et al. A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report. Trans. R. Soc. Trop. Med. Hyg. 83:1989;607-608.
70. Mason D.P., et al. Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria? Southeast Asian J. Trop. Med. Public Health. 32:2001;57-63.